Arcturus Therapeutics Holdings Inc. (ARCT) › RevenueArcturus Therapeutics Holdings Inc. (ARCT) — RevenueAnnual figures by fiscal year, from SEC filings.2018: $15.75M2019: $20.79M2020: $9.54M2021: $12.36M2022: $206.00M2023: $166.80M2024: $152.31M2025: $82.03M$82.03M2018Revenue (USD)2025Fiscal YearRevenueChange YoY2025$82.03M-46.1%2024$152.31M-8.7%2023$166.80M-19.0%2022$206.00M+1566.8%2021$12.36M+29.6%2020$9.54M-54.1%2019$20.79M+32.0%2018$15.75M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share